The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study.

ABSTRACT:

Background

A patient is considered to suffer from treatment resistant depression (TRD) when consecutive treatment with two products of different pharmacological classes, used for a sufficient length of time at an adequate dose, fail to induce a clinically meaningful effect (inadequate response). The primary aim of the current study was to examine the humanistic and economic burden of TRD in five European countries, France, Germany, Italy, Spain and the United Kingdom, by comparing with non-treatment resistant depression (nTRD) and general population respondents.

Methods

The sample for this retrospective observational study was taken from the 2017 National Health and Wellness Survey conducted in five European countries. Demographic and patient characteristics were examined fo

SUBMITTER: Jaffe DH 

PROVIDER: S-EPMC6686569 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature